"mRNAワクチン" の関連情報検索結果
mRNA vaccine immunity is enhanced by hepatocyte detargeting and not dependent on dendritic cell e...

Investigational Pancreatic Cancer Vaccine Shows Lasting Results in Early Trial, Supporting Contin...

Investigational Pancreatic Cancer Vaccine Shows Lasting Results in Early Trial, Supporting Continued Testing Memorial Sloan Kettering Cancer Center
Efficacy, Immunogenicity, and Safety of Modified mRNA Influenza Vaccine - The New England Journal...

Efficacy, Immunogenicity, and Safety of Modified mRNA Influenza Vaccine The New England Journal of Medicine
Scientists in Korea to create mRNA vaccine against emerging Asian tick-borne virus - CEPI

Scientists in Korea to create mRNA vaccine against emerging Asian tick-borne virus CEPI
Stanford Medicine study shows why mRNA COVID-19 vaccine can cause myocarditis - Stanford Medicine

Stanford Medicine study shows why mRNA COVID-19 vaccine can cause myocarditis Stanford Medicine
Pancreatic cancer mRNA vaccine shows lasting results in an early trial - NBC News

Pancreatic cancer mRNA vaccine shows lasting results in an early trial NBC News
Moderna gets $50 million to develop mRNA Ebola vaccine against Bundibugyo - Ars Technica

Moderna gets $50 million to develop mRNA Ebola vaccine against Bundibugyo Ars Technica
ESMO 2025: mRNA-based COVID vaccines generate improved responses to immunotherapy - UT MD Anderson

ESMO 2025: mRNA-based COVID vaccines generate improved responses to immunotherapy UT MD Anderson
Experimental mRNA flu vaccine shows superior efficacy against symptomatic illness - CIDRAP

Experimental mRNA flu vaccine shows superior efficacy against symptomatic illness CIDRAP
Risks of Cuts to mRNA Vaccine Development - Johns Hopkins Bloomberg School of Public Health

Risks of Cuts to mRNA Vaccine Development Johns Hopkins Bloomberg School of Public Health
Senate Hearing Questions COVID Vaccine Safety - Legis1

Adverse events following SARS-CoV-2 mRNA vaccination in norwegian adolescents - Nature

Adverse events following SARS-CoV-2 mRNA vaccination in norwegian adolescents Nature
CEPI to Fund Pivotal Phase 3 Trial for Moderna’s mRNA Pandemic Influenza Candidate - CEPI

CEPI to Fund Pivotal Phase 3 Trial for Moderna’s mRNA Pandemic Influenza Candidate CEPI
Europe—not US—first to authorize Moderna’s combo mRNA flu-COVID vaccine - Ars Technica

Europe—not US—first to authorize Moderna’s combo mRNA flu-COVID vaccine Ars Technica
Mitochondrial vulnerability underlies myocarditis from COVID-19 mRNA vaccine - Nature

Mitochondrial vulnerability underlies myocarditis from COVID-19 mRNA vaccine Nature
A structure-based mRNA vaccine for Nipah virus in healthy adults: a phase 1 trial - Nature

A structure-based mRNA vaccine for Nipah virus in healthy adults: a phase 1 trial Nature
Tuning the immune response to mRNA vaccines - Nature

SARS-CoV-2 mRNA vaccines sensitize tumours to immune checkpoint blockade - Nature

SARS-CoV-2 mRNA vaccines sensitize tumours to immune checkpoint blockade Nature
Individualized mRNA vaccines evoke durable T cell immunity in adjuvant TNBC - Nature

Individualized mRNA vaccines evoke durable T cell immunity in adjuvant TNBC Nature
People with some cancers live longer after a COVID vaccine - Nature

People with some cancers live longer after a COVID vaccine Nature
DNA origami vaccines could be the next leap beyond mRNA - ScienceDaily

DNA origami vaccines could be the next leap beyond mRNA ScienceDaily
COVID-19 mRNA Vaccines May Boost Immunotherapy, Doubling Survival in Aggressive Cancers - Inside ...

COVID-19 mRNA Vaccines May Boost Immunotherapy, Doubling Survival in Aggressive Cancers Inside Precision Medicine
What are the biggest vaccine breakthroughs coming in 2026? We asked five experts - Gavi, the Vacc...

What are the biggest vaccine breakthroughs coming in 2026? We asked five experts Gavi, the Vaccine Alliance
Personalized cancer vaccines are almost here—but federal funding cuts could derail them - Scienti...

Personalized cancer vaccines are almost here—but federal funding cuts could derail them Scientific American
FDA reverses course, will review Moderna’s mRNA flu vaccine candidate - The Hill

FDA reverses course, will review Moderna’s mRNA flu vaccine candidate The Hill
Combined Adaptive Immune Mechanisms Mediate Cardiac Injury After COVID-19 Vaccination - American ...

Combined Adaptive Immune Mechanisms Mediate Cardiac Injury After COVID-19 Vaccination American Heart Association Journals
Study finds mRNA coronavirus vaccines prolonged life of cancer patients - The Washington Post

Study finds mRNA coronavirus vaccines prolonged life of cancer patients The Washington Post
mRNA vaccines for HIV trigger strong immune response in people - Nature

mRNA vaccines for HIV trigger strong immune response in people Nature
Bayer sues COVID vaccine makers over mRNA technology - Reuters

Bayer sues COVID vaccine makers over mRNA technology Reuters
Massive four-year study finds no increase in deaths linked to COVID-19 mRNA vaccination - Gavi, t...

Massive four-year study finds no increase in deaths linked to COVID-19 mRNA vaccination Gavi, the Vaccine Alliance
Moderna wins EU approval for combined flu, COVID shot for older adults - Reuters

Moderna wins EU approval for combined flu, COVID shot for older adults Reuters
RFK Jr cancels $500m in mRNA vaccine development in the US - BBC

RFK Jr cancels $500m in mRNA vaccine development in the US BBC
RFK Jr. cancels at least $500M in mRNA vaccine funding. What are the implications? - ABC News - B...

RFK Jr. cancels at least $500M in mRNA vaccine funding. What are the implications? ABC News - Breaking News, Latest News and Videos
MHRA approves zapomeran (Kostaive) mRNA COVID-19 vaccine - GOV.UK

MHRA approves zapomeran (Kostaive) mRNA COVID-19 vaccine GOV.UK
Six companies leading the mRNA revolution in biotechnology - Labiotech.eu

Six companies leading the mRNA revolution in biotechnology Labiotech.eu
Moderna's reshaping rolls on with 3 more pipeline purges - Fierce Biotech

Moderna's reshaping rolls on with 3 more pipeline purges Fierce Biotech
Vaccine Makers Curtail Research and Cut Jobs - The New York Times

Vaccine Makers Curtail Research and Cut Jobs The New York Times
RFK Jr. pulls $500 million in funding for vaccine development - ABC7 Los Angeles

RFK Jr. pulls $500 million in funding for vaccine development ABC7 Los Angeles
KDCA readies mRNA vaccines, tech for COVID-19, future outbreaks - BioWorld News

KDCA readies mRNA vaccines, tech for COVID-19, future outbreaks BioWorld News
Moderna Stock Climbs After Hantavirus Vaccine: Data Triggers Analyst Price Target - Investing.com

Moderna Stock Climbs After Hantavirus Vaccine: Data Triggers Analyst Price Target Investing.com
Moderna Flu Breakthrough And Hantavirus Push Reframe Long Term Story - Yahoo Finance

Moderna Flu Breakthrough And Hantavirus Push Reframe Long Term Story Yahoo Finance
Respirology Case Reports | APSR Respiratory Medicine Journal - Wiley Online Library

Respirology Case Reports | APSR Respiratory Medicine Journal Wiley Online Library
Korea University and Moderna have been working on mRNA hantavirus vaccine since 2023 - Brussels S...

Korea University and Moderna have been working on mRNA hantavirus vaccine since 2023 Brussels Signal
CureVac is now part of the BioNTech Group - Cure Vac

Tech boss uses ChatGPT to create cancer vaccine to save dying dog - The Australian

Tech boss uses ChatGPT to create cancer vaccine to save dying dog The Australian
FDA Updates CV Warnings Around COVID-19 mRNA Vaccines - TCTMD.com

FDA Updates CV Warnings Around COVID-19 mRNA Vaccines TCTMD.com
Creating the Next Generation of mRNA Vaccines - Harvard Medical School

Creating the Next Generation of mRNA Vaccines Harvard Medical School
Trump and RFK Jr. to Ban COVID-19 Vaccine ‘Within Months’ - The Daily Beast

Trump and RFK Jr. to Ban COVID-19 Vaccine ‘Within Months’ The Daily Beast
COVID-19 mRNA Vaccine Production - National Human Genome Research Institute (NHGRI) (.gov)

COVID-19 mRNA Vaccine Production National Human Genome Research Institute (NHGRI) (.gov)
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine - The New England Journal of Medicine

Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine The New England Journal of Medicine
Comparing the COVID-19 Vaccines: How Are They Different? - Yale Medicine

Comparing the COVID-19 Vaccines: How Are They Different? Yale Medicine
An mRNA-based T-cell-inducing antigen strengthens COVID-19 vaccine against SARS-CoV-2 variants - ...

An mRNA-based T-cell-inducing antigen strengthens COVID-19 vaccine against SARS-CoV-2 variants Nature
The Science Behind The Historic mRNA Vaccine : Short Wave - NPR

The Science Behind The Historic mRNA Vaccine : Short Wave NPR
Seasonal quadrivalent mRNA vaccine prevents and mitigates influenza infection | npj Vaccines - Na...

Seasonal quadrivalent mRNA vaccine prevents and mitigates influenza infection | npj Vaccines Nature
Effectiveness of mRNA Covid-19 Vaccine among U.S. Health Care Personnel - The New England Journal...

Effectiveness of mRNA Covid-19 Vaccine among U.S. Health Care Personnel The New England Journal of Medicine
An mRNA Vaccine against SARS-CoV-2 — Preliminary Report - The New England Journal of Medicine

An mRNA Vaccine against SARS-CoV-2 — Preliminary Report The New England Journal of Medicine
Use of mRNA COVID-19 Vaccine After Reports of ... - Centers for Disease Control and Prevention | ...

Use of mRNA COVID-19 Vaccine After Reports of ... Centers for Disease Control and Prevention | CDC (.gov)
Safety of the BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Setting - The New England Journal of...

Safety of the BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Setting The New England Journal of Medicine
Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine - The New England Journal of Medicine

Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine The New England Journal of Medicine
Features of chronic urticaria after COVID-19 mRNA vaccine over time | Communications Medicine - N...

Features of chronic urticaria after COVID-19 mRNA vaccine over time | Communications Medicine Nature
Moderna says mRNA flu vaccine sailed through trial, beating standard shot - Ars Technica

Moderna says mRNA flu vaccine sailed through trial, beating standard shot Ars Technica
Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults - The New England Journ...

Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults The New England Journal of Medicine
NIH cuts funding for vaccine-hesitancy research. mRNA research may be next - NPR

NIH cuts funding for vaccine-hesitancy research. mRNA research may be next NPR
What are mRNA vaccines and how do they work? - GOV.UK blogs

What are mRNA vaccines and how do they work? GOV.UK blogs
Duration of SARS-CoV-2 mRNA vaccine persistence and factors associated with cardiac involvement i...

A multiclade env–gag VLP mRNA vaccine elicits tier-2 HIV-1-neutralizing antibodies and reduces th...

How mRNA Vaccines Might Help Treat Cancer - National Cancer Institute (.gov)

How mRNA Vaccines Might Help Treat Cancer National Cancer Institute (.gov)
Safety, immunogenicity and efficacy of the self-amplifying mRNA ARCT-154 COVID-19 vaccine: pooled...

mRNA vaccines for infectious diseases: principles, delivery and clinical translation - Nature

mRNA vaccines for infectious diseases: principles, delivery and clinical translation Nature
Development of mRNA vaccine indicating therapeutic effect against gastric cancer with peritoneal ...

NIH to ax grants on vaccine hesitancy - Science | AAAS

NIH to ax grants on vaccine hesitancy Science | AAAS
Personalized RNA neoantigen vaccines stimulate T cells in pancreatic cancer - Nature

Personalized RNA neoantigen vaccines stimulate T cells in pancreatic cancer Nature
The tangled history of mRNA vaccines - Nature

mRNA COVID vaccines saved lives and won a Nobel — what’s next for the technology? - Nature

mRNA COVID vaccines saved lives and won a Nobel — what’s next for the technology? Nature
Infection or a third dose of mRNA vaccine elicits neutralizing antibody responses against SARS-Co...

Infection or a third dose of mRNA vaccine elicits neutralizing antibody responses against SARS-CoV-2 in kidney transplant recipients Science | AAAS
Reevaluation of antibody-dependent enhancement of infection in anti-SARS-CoV-2 therapeutic antibo...

Japan Approves Updated Self-Amplifying mRNA COVID-19 Vaccine - Contagion Live

Japan Approves Updated Self-Amplifying mRNA COVID-19 Vaccine Contagion Live
Polymer nanoparticles deliver mRNA to the lung for mucosal vaccination - Science | AAAS

Polymer nanoparticles deliver mRNA to the lung for mucosal vaccination Science | AAAS
Effectiveness of mRNA BNT162b2 COVID-19 vaccine up to 6 months in a large integrated health syste...

RNA vaccines: the way of the future? - American Animal Hospital Association - AAHA

RNA vaccines: the way of the future? American Animal Hospital Association - AAHA
Next generation self-replicating RNA vectors for vaccines and immunotherapies | Cancer Gene Thera...

Next generation self-replicating RNA vectors for vaccines and immunotherapies | Cancer Gene Therapy Nature
Katalin Karikó and Drew Weissman were jointly awarded the Nobel Prize in Physiology or Medicine 2...

Katalin Karikó and Drew Weissman were jointly awarded the Nobel Prize in Physiology or Medicine 2023 World Health Organization (WHO)
The direct effect of SARS-CoV-2 virus vaccination on human ovarian granulosa cells explains menst...

High coverage COVID-19 mRNA vaccination rapidly controls SARS-CoV-2 transmission in long-term car...

Prevention and Attenuation of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines - The New England...

Prevention and Attenuation of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines The New England Journal of Medicine
Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults - Nature

Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults Nature
Impact of sex and age on vaccine-related side effects and their progression after booster mRNA CO...

Moderna/Merck begins late-stage study of skin cancer vaccine combination - Reuters

Moderna/Merck begins late-stage study of skin cancer vaccine combination Reuters
Adults Vaccines Market Size, Share | Growth Report [2034] - Fortune Business Insights

Adults Vaccines Market Size, Share | Growth Report [2034] Fortune Business Insights
The U.S. Department of Health and Human Services has withdrawn funding for mRNA vaccine developme...

Universal flu vaccine based on mRNA tech to be tested by National Institutes of Health - NBC News

Universal flu vaccine based on mRNA tech to be tested by National Institutes of Health NBC News
Class switch towards spike protein-specific IgG4 antibodies after SARS-CoV-2 mRNA vaccination dep...

Moderna and Korea University to co-develop hantavirus vaccine - koreabiomed.com

Moderna and Korea University to co-develop hantavirus vaccine koreabiomed.com
Safety of mRNA vaccines administered during the initial 6 months of the US COVID-19 vaccination p...

Hopes Are Rising for a Homegrown mRNA Vaccine in China - Bloomberg.com

Hopes Are Rising for a Homegrown mRNA Vaccine in China Bloomberg.com
Africa’s first mRNA vaccine technology transfer hub gets to work - The Conversation

Africa’s first mRNA vaccine technology transfer hub gets to work The Conversation
Moderna's groundbreaking coronavirus vaccine was designed in just 2 days - Business Insider

Moderna's groundbreaking coronavirus vaccine was designed in just 2 days Business Insider
Antibodies elicited by SARS-CoV-2 infection or mRNA vaccines have reduced neutralizing activity a...

Antibodies elicited by SARS-CoV-2 infection or mRNA vaccines have reduced neutralizing activity against Beta and Omicron pseudoviruses Science | AAAS
Does Chinese tech giant’s AI algorithm hold the key to better mRNA vaccines? - South China Mornin...

Does Chinese tech giant’s AI algorithm hold the key to better mRNA vaccines? South China Morning Post
Beyond COVID vaccines: what’s next for lipid nanoparticles? - Nature

Beyond COVID vaccines: what’s next for lipid nanoparticles? Nature